Literature DB >> 2434416

Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.

M Heiskala.   

Abstract

Natural killer (NK) activity is inhibited by the contact of peripheral blood lymphocytes with primary monolayer cell cultures of both benign and malignant origin. In this study the effect of interferons (IFNs) on the inhibition has been analysed. Both alpha IFN- and gamma IFN-pretreated peripheral blood lymphocytes are effectively inhibited by monolayer target cells. IFN treatment of lymphocytes does not change cytotoxicity against the inhibitory target cells, although it enhances reactivity against NK-sensitive target cells. Treatment of monolayer cells with interferons significantly reduces their inhibitory capacity. However, diminished inhibition of NK activity by the IFN-treated target cells is not associated with increased lysis, probably due to their decreased sensitivity to natural killer cytotoxic factors (NKCF). In 18.5% of the cases studied, monolayer target cells induced endogenous IFN production in lymphocytes. In these cases no inhibition of the NK activity of the effector cells was seen. According to the results of this paper, IFNs have a dual effect on the NK regulatory system: they enhance the NK activity of the effector cells against NK-sensitive target cells, and they change the NK resistant target cells in a way that makes them less inhibitory to NK activity but simultaneously more resistant to the toxic factors secreted by NK cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434416      PMCID: PMC1453230     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Human leukocyte interferon: a role for disulphide bonds.

Authors:  K E Mogensen; K Cantell
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

2.  Effect of interferon and interferon inducers on the NK sensitivity of normal mouse thymocytes.

Authors:  M Hansson; R Kiessling; B Andersson; R M Welsh
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

3.  Modulation of target cell susceptibility to human natural killer cells by interferon.

Authors:  M Moore; W J White; M R Potter
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

4.  Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells.

Authors:  R M Welsh; K Karre; M Hansson; L A Kunkel; R W Kiessling
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

5.  Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.

Authors:  G Trinchieri; D Granato; B Perussia
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.

Authors:  S C Wright; B Bonavida
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

8.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.

Authors:  G Trinchieri; D Santoli; R R Dee; B B Knowles
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Recycling and target binding capacity of human natural killer cells.

Authors:  M Ullberg; M Jondal
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  2 in total

1.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

Review 2.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.